Abbott Beats on EPS, Affirms ViewZacks.comAbbott Labs, along with partner Biogen (BIIB – Analyst Report), is evaluating daclizumab in a phase III study for the treatment of relapsing-remitting multiple sclerosis (RRMS). Abbott Labs is also working on l…
Dr Reddy's bets big on biosimilars, eyes regulated marketsEconomic TimesAt present, DRL's biosimilars portfolio includes filgrastim, peg-filgrastim, rituximab and darbepoetin alfa, which have commercial presence in 13 countries among emerging m…
Abbott Reports Strong Second Quarter ResultsMarketWatch (press release)Abbott is partnering on the development of a novel, next-generation antibody, daclizumab, which is currently in Phase 3 clinical trials for MS. Additionally, Abbott recently announc…
각종 신계열 신약 출시 기대디지틀보사… C형 간염에 '아수나프레비어'(asunaprevir), 'BI 201335', '시메프레비어'(simeprevir), 다발성 경화증에 면역조절제인 '라퀴니모드'(laqu…
Sports fun day to raise cash for patient's drugsDerby TelegraphHer family and friends have raised thousands of pounds towards the cost of a drug called Rituximab which is not available on the NHS in the East Midlands and costs £25000 a year. On Sa…
Plan Set for Charlie's Second Stem Cell TransplantWGBA-TVAfter weeks of pain and discomfort, doctors at Children's Hospital in Minneapolis have started the medication Rituximab designed to help Charlie's stomach feel better. Trisha Knuth wr…
AGI – Agenzia Giornalistica ItaliaStaminali: anticorpo di conigli riduce rigetto nei trapiantiAGI – Agenzia Giornalistica ItaliaGli scienziati hanno studiato le reazioni in 50 soggetti a cui erano state trapiantate cellule staminali da donatore non par…
One-quarter of ITP patients achieve 5-year treatment-free responseNews-Medical.netApproximately 25% of patients with immune thrombocytopenia purpura who receive treatment with rituximab maintain a treatment-free response lasting for at least 5 years, s…
Daily MailParched and tired all the time? You could have 'dry body' syndromeDaily MailDr Bowman is leading a £1 million clinical trial on behalf of Arthritis Research UK looking at the drug Rituximab. This is licensed to treat severe rheumatoi…
Storm Davis UpdateFranklin News PostCheyenne Storm Davis, 13, of Callaway must spend a month waiting for the results from a Rituximab treatment before learning if she is eligible for another kidney transplant. The teen, who has had kidney problems sinc…